Basal segment deep wedge resection for lung cancer with pulmonary fibrosis.

Idiopathic pulmonary fibrosis Interstitial lung disease Lung neoplasms Non-small-cell lung carcinoma Wedge resection

Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 28 10 2021
accepted: 15 12 2021
pubmed: 28 1 2022
medline: 22 3 2022
entrez: 27 1 2022
Statut: ppublish

Résumé

Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is among the most fatal postoperative complications of lung resection in patients with IPF. Non-small-cell lung cancer (NSCLC) with IPF exhibits basal segment dominance. Treatment options for these lesions include lobectomy or basal segment segmentectomies. However, these procedures potentially increase risks of AE due to surgical stress including prolonged operative time and loss of pulmonary function. Therefore, as an alternative to these procedures, we developed a simple and practical deep wedge resection technique for basal segments. Our technique is minimally invasive and quick and simple approach in patients with NSCLC and IPF.

Identifiants

pubmed: 35083641
doi: 10.1007/s11748-021-01764-5
pii: 10.1007/s11748-021-01764-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-415

Informations de copyright

© 2021. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.

Références

Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604-1611.e3.
doi: 10.1016/j.jtcvs.2013.09.050
Lee T, Park JY, Lee HY, Cho YJ, Yoon HI, Lee JH, et al. Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival. Respir Med. 2014;108:1549–55.
doi: 10.1016/j.rmed.2014.07.020
Watanabe A, Miyajima M, Mishina T, Nakazawa J, Harada R, Kawaharada N, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen Thorac Cardiovasc Surg. 2013;61:254–61.
doi: 10.1007/s11748-012-0180-6
Tsutani Y, Mimura T, Kai Y, Ito M, Misumi K, Miyata Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089-1096.e1.
doi: 10.1016/j.jtcvs.2017.03.116
Endoh M, Oizumi H, Kato H, Suzuki J, Watarai H, Masaoka T, et al. Posterior approach to thoracoscopic pulmonary segmentectomy of the dorsal basal segment: a single-institute retrospective review. J Thorac Cardiovasc Surg. 2017;154:1432–9.
doi: 10.1016/j.jtcvs.2017.03.120
Tanaka K, Tsutani Y, Wakabayashi M, Mizutani T, Aokage K, Miyata Y, et al. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE trial). Jpn J Clin Oncol. 2020;50:1076–9.
doi: 10.1093/jjco/hyaa092

Auteurs

Shinya Tane (S)

Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan. shinyatane@gmail.com.

Yuko Ando (Y)

Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.

Gaku Matsumoto (G)

Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.

Shinsaku Ueda (S)

Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.

Kazuya Uchino (K)

Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH